Immitra Bio | Biotech & Life Sciences | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Immitra Bio

Company Overview Backed By Recent Activity Similar Companies Startup DNA

Immitra Bio

Immitra Bio is a Zürich-based genetic medicine platform bringing scalability and commercial viability to gene editing therapies

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Immitra Bio is a Zürich-based genetic medicine platform bringing scalability and commercial viability to gene editing therapies. The company is developing an in vivo gene-editing platform that aims to treat genetic diseases more efficiently by eliminating the need for gene insertion and chemotherapy.

02Backed By2 investors

BVBackbone Ventures→OOccident→

Is this your company? Claim your profile

Startup Intelligence by F4F4 Research Engine

Recent Activity

FROM Backbone Ventures

Backed Immitra Bio, an ETH Zurich spin-off developing CRISPR-Cas9 gene editing therapies for rare diseases.

INVESTMENT·backbone.vc

Added recently

FROM Occident

Participated in Immitra Bio's CHF 2.4M Pre-Seed round for an in-vivo gene therapy platform for rare genetic diseases.

INVESTMENT·occident.group

JUL 21, 2026

04Similar Companies

CM

Chroma Medicine

Biotech & Life Sciences

→

AT

Addition Therapeutics

Biotech & Life Sciences

→

VT

Verve Therapeutics

Biotech & Life Sciences

→

EB

Eligo Bioscience

Biotech & Life Sciences

→

AT

AERA Therapeutics

Biotech & Life Sciences

→

05Startup DNA

signals

Sectors
Business Model
Technology

Quick Reference

Sector

Biotech & Life Sciences · Healthcare & Digital Health